Pharmaco-miR: linking microRNAs and drug effects

Area of Science:

• Genomics
• Molecular Biology
• Pharmacology

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression involved in cellular homeostasis and disease.
• miRNAs significantly influence drug efficacy, leading to the development of miRNA pharmacogenomics and Pharmaco-miRs.
• Drug response can be modulated by miRNA interactions with target genes, forming miRNA-gene-drug triplets.

Purpose of the Study:

• To develop a web server and database for exploring miRNA-gene-drug interactions in pharmacogenomics.
• To link miRNA expression patterns with drug efficacy and function.
• To provide a resource for understanding how miRNAs affect drug response and to curate literature data.

Main Methods:

• Developed the Pharmaco-miR web server integrating miRNA targeting data (experimental and computational) and protein-drug interactions from PharmGKB.
• Implemented a database, Pharmaco-miR Verified Sets (VerSe), for manually curated miRNA pharmacogenomic data from scientific literature.
• Designed the server to accept miRNA, gene, or drug names as input to identify associated pharmacogenomic sets or lists.

Main Results:

• The Pharmaco-miR server successfully links miRNA expression to drug function through identified miRNA-gene-drug interactions.
• The VerSe database offers a curated collection of miRNA pharmacogenomic information for trend analysis.
• Demonstrated the utility of Pharmaco-miR by explaining miR-148a's role in cisplatin and 5-fluorouracil resistance via KIT gene targeting.

Conclusions:

• Pharmaco-miR serves as a valuable resource for investigating miRNA pharmacogenomics and understanding drug response mechanisms.
• The integrated approach of combining miRNA targeting and drug interaction data provides novel insights into drug efficacy.
• The findings highlight the potential of targeting miRNAs for personalized medicine and improving therapeutic outcomes.